Stock listing
Lang & Schwarz:A2QA1Z EMV Capital PLC Aktie
German listing (Lang & Schwarz) of EMV Capital PLC · home listing LSE:EMVC
Follow EMV Capital PLC into a list and get an email when it puts out news.
Home listing price · LSE:EMVC
45.00p GBX (pence) 0.00 (0.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:EMVC
- Day range
- 43.00p – 47.00p GBX (pence)Nov 20, 2026
- Volume
- 13,247 sharesNov 20, 2026
- Market cap
- £12.69M GBPAt the close on Nov 20, 2026 · price × 28.21M shares outstanding
- 52-week range
- 40.00p – 62.00p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- £12,591 GBPMedian day 13,192 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:EMVC · Home | 45.00p GBX (pence) | 0.00 (0.0%) | 13,247 | 47.00p | 47.00p | 43.00p | 45.00p | Close on Nov 20, 2026 |
| Frankfurt:NTK1 | €0.466 EUR | -0.002 (-0.4%) | — | €0.466 | €0.466 | €0.466 | €0.468 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:EMVC · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 45.00p | 0.00 | 0.0% | 47.00p | 47.00p | 43.00p | 13,247 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 45.00p | 43.00p | 143,789 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 45.00p | 43.00p | 143,789 | |
| 45.00p | +2.00 | +4.7% | 44.20p | 47.00p | 43.40p | 117,355 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.55p | 9,838 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.55p | 9,838 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.24p | 16,968 | |
| 43.00p | 0.00 | 0.0% | 41.00p | 45.00p | 41.00p | 9 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.00p | 3,659 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.24p | 5,019 | |
| 43.00p | 0.00 | 0.0% | 43.00p | 43.00p | 41.24p | 5,019 | |
| 43.00p | +1.50 | +3.6% | 41.50p | 43.00p | 41.05p | 92,335 | |
| 41.50p | -0.50 | -1.2% | 40.00p | 41.78p | 40.00p | 20,439 | |
| 42.00p | 0.00 | 0.0% | 41.25p | 43.00p | 41.25p | 18,343 | |
| 42.00p | 0.00 | 0.0% | 42.00p | 42.00p | 41.55p | 10,693 | |
| 42.00p | 0.00 | 0.0% | 42.00p | 42.50p | 42.00p | 4,697 | |
| 42.00p | 0.00 | 0.0% | 42.00p | 42.50p | 42.00p | 4,697 | |
| 42.00p | +1.00 | +2.4% | 41.75p | 43.00p | 41.20p | 31,660 | |
| 41.00p | -1.50 | -3.5% | 43.00p | 43.00p | 40.00p | 12,404 | |
| 42.50p | 0.00 | 0.0% | 42.70p | 42.70p | 42.00p | 5,107 | |
| 42.50p | -3.00 | -6.6% | 45.50p | 46.00p | 42.00p | 62,582 | |
| 45.50p | 0.00 | 0.0% | 45.50p | 47.00p | 44.18p | 13,192 | |
| 45.50p | -1.00 | -2.2% | 46.50p | 48.00p | 44.67p | 38,154 | |
| 46.50p | -0.50 | -1.1% | 47.00p | 48.00p | 45.00p | 5,388 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 47.00p | 46.52p | 6,500 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 49.00p | 47.00p | 4,555 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 47.75p | 46.13p | 14,400 | |
| 47.00p | +2.00 | +4.4% | 45.00p | 49.00p | 44.20p | 78,030 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 45.00p | 44.50p | 5,637 | |
| 45.00p | +0.50 | +1.1% | 44.50p | 46.00p | 44.00p | 13,245 | |
| 44.50p | 0.00 | 0.0% | 44.50p | 46.00p | 43.00p | 102,075 | |
| 44.50p | +0.50 | +1.1% | 44.50p | 46.00p | 44.50p | 14,665 | |
| 44.00p | 0.00 | 0.0% | 44.00p | 45.00p | 43.00p | 8,294 | |
| 44.00p | -1.00 | -2.2% | 45.00p | 46.00p | 43.00p | 57,458 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 47.00p | 43.55p | 17,136 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 47.00p | 43.55p | 38,664 | |
| 45.00p | 0.00 | 0.0% | 45.00p | 47.00p | 43.55p | 7,209 | |
| 45.00p | -2.00 | -4.3% | 47.00p | 49.00p | 43.00p | 9,720 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 49.00p | 44.13p | 39,488 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 49.00p | 45.75p | 12,828 | |
| 47.00p | -1.50 | -3.1% | 48.50p | 50.00p | 46.10p | 76,092 | |
| 48.50p | +1.50 | +3.2% | 47.00p | 50.00p | 46.00p | 47,321 | |
| 47.00p | +1.50 | +3.3% | 45.60p | 48.00p | 45.60p | 67,139 | |
| 45.50p | +1.00 | +2.2% | 44.50p | 47.00p | 44.00p | 25,988 | |
| 44.50p | 0.00 | 0.0% | 44.50p | 45.00p | 44.16p | 2,514 | |
| 44.50p | -1.00 | -2.2% | 45.50p | 46.00p | 44.16p | 29,653 | |
| 45.50p | 0.00 | 0.0% | 45.50p | 45.50p | 44.70p | 1,801 | |
| 45.50p | -1.50 | -3.2% | 47.00p | 48.00p | 45.00p | 4,486 | |
| 47.00p | 0.00 | 0.0% | 47.00p | 48.00p | 46.05p | 69,965 | |
| 47.00p | -0.80 | -1.7% | 47.00p | 47.00p | 46.50p | 19,434 | |
| 47.80p | 0.00 | 0.0% | 47.80p | 47.80p | 46.60p | 3,068 | |
| 47.80p | -0.70 | -1.4% | 47.80p | 47.80p | 46.60p | 5,750 | |
| 48.50p | 0.00 | 0.0% | 48.50p | 50.00p | 47.00p | 6,156 | |
| 48.50p | 0.00 | 0.0% | 48.50p | 48.50p | 47.00p | 9,603 | |
| 48.50p | -2.00 | -4.0% | 50.50p | 51.00p | 47.18p | 16,206 | |
| 50.50p | 0.00 | 0.0% | 50.50p | 52.00p | 49.11p | 5,552 | |
| 50.50p | 0.00 | 0.0% | 50.50p | 52.00p | 49.18p | 1,323 | |
| 50.50p | 0.00 | 0.0% | 50.50p | 50.50p | 49.10p | 9,732 | |
| 50.50p | -0.50 | -1.0% | 51.00p | 52.00p | 49.50p | 34,927 | |
| 51.00p | -1.00 | -1.9% | 52.00p | 53.00p | 50.00p | 58,856 | |
| 52.00p | -1.00 | -1.9% | 53.00p | 54.00p | 52.00p | 19,095 | |
| 53.00p | 0.00 | 0.0% | 53.00p | 54.00p | 52.12p | 3,329 | |
| 53.00p | -0.50 | -0.9% | 53.50p | 53.50p | 51.00p | 37,354 | |
| 53.50p | 0.00 | 0.0% | 53.50p | 53.77p | 52.00p | 1,107 | |
| 53.50p | 0.00 | 0.0% | 53.50p | 54.50p | 52.30p | 12,675 |
Splits
1 split · LSE:EMVC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- Lang & Schwarz:A2QA1Z
- Asset type
- Stock
- Sector
- Financials
- Industry
- Investment companies & funds
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 16, 2026
AMR bio: constructive type b FDA meeting for XF-73
Latest earnings call · Jul 27, 2026
EMV Capital (LSE:EMVC) — Virtual Meet the Portfolio - AMR Bio and ProAxsis
Replay and transcript
Latest deck · Sep 24, 2026
H1 2026 Earnings Presentation
Earnings · 27 slides
Latest news
AMR bio: constructive type b FDA meeting for XF-73
Nov 16, 2026
Closed 45.00p (+4.7%) on Nov 16, 2026
Change of nominated adviser and change of broker
Nov 9, 2026
Closed 43.00p (0.0%) on Nov 9, 2026
Issue of Shares, PDMR Dealing, Total Voting Rights
Nov 5, 2026
Closed 43.00p (0.0%) on Nov 5, 2026
Glycotest Licenses IP from S. Carolina university
Oct 13, 2026
Closed 47.00p (+4.4%) on Oct 13, 2026
Interim Results 2026 - Report
Sep 24, 2026
Closed 47.00p (0.0%) on Sep 25, 2026
New Portfolio Company Acquires Recycling Plant
Sep 14, 2026
Closed 47.00p (0.0%) on Sep 14, 2026
Portfolio Update and Presentation
Jul 13, 2026
Closed 52.50p (-0.9%) on Jul 13, 2026
Portfolio Update: Glycotest and ProAxsis
Jul 1, 2026
Closed 51.50p (0.0%) on Jul 1, 2026
AMR Bio: Commercial Update
May 21, 2026
Closed 45.00p (-3.2%) on May 21, 2026
Final Results for the year ended 31 December 2025
May 19, 2026
Closed 46.50p (-3.1%) on May 19, 2026
EMV Capital PLC on 6ix
- Sector
- Financials
- Industry
- Investment companies & funds
- News releases
- 19 in the last 12 months · 348 in all · newest Nov 16, 2026 · oldest 2013
- Calls
- 14 calls with a replay · 14 with a transcript · latest Jul 27, 2026
- Decks
- 17 decks · latest Sep 24, 2026
Where EMV Capital PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:EMVC · Home listing | LSE | United Kingdom | GBX |
| Frankfurt:NTK1 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QA1Z · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QA1Z | LS Exchange | Germany | EUR |
| Stuttgart:NTK1 | Stuttgart | Germany | EUR |
Valuation
EV/sales 4.5× against a median of 5.9×: 5th lowest of 9 Investment companies & funds companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- £12.85M GBP
- P/E
- Loss
- EV/sales
- 4.5×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.4×
- Gross margin
- 78.5%
- Operating margin
- −65.5%
- Net margin
- −0.7%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Investment companies & funds: the 10 companies nearest in size, of 321 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| EMV Capital PLC · LSE:EMVC | US$16.60M | US$16.81M | n/a | 4.5× | n/a | 0.4× | −0.7% | 0.0× | n/a |
| Wilmington Capital Management Inc. Class A · TSX:WCM.A | US$18.52M | US$16.74M | 3.3× | 10.7× | 3.1× | 0.6× | 359.9% | 0.0× | 0.30 |
| ORECAP Invest Corp · TSXV:OCI | US$18.18M | −US$11.59M | 1.4× | n/a | n/a | 0.6× | n/a | 0.0× | 1.08 |
| Panostaja Oyj · OMXHEX:PNA1V | US$18.04M | US$59.64M | n/a | 0.5× | 1.3× | 0.8× | −3.9% | 2.6× | n/a |
| Innovative-RFK SpA · EURONEXT:MLIRF | US$17.97M | US$18.17M | 11.8× | 42.7× | n/a | 1.3× | 359.0% | 0.1× | n/a |
| Numeral Limited · JSE:XII | US$17.66M | US$22.23M | n/a | 10.5× | 21.2× | 23.5× | −1.9% | 6.3× | n/a |
| Mineral and Financial Investments Ltd · LSE:MAFL | US$17.03M | US$631,481 | 6.0× | 0.3× | n/a | 0.8× | 156.9% | 0.0× | n/a |
| China Innovation Investment Limited · HKEX:1217 | US$16.33M | −US$15.36M | 2.3× | −1.9× | −2.1× | 0.2× | 87.8% | 0.0× | n/a |
| SRx Health Solutions, Inc. · AMEX:SRXH | US$16.21M | −US$26.48M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 1.33 |
| Frontier IP Group PLC · LSE:FIPP | US$16.21M | US$30.65M | n/a | 72.1× | n/a | 0.3× | n/a | 0.3× | n/a |
| Trematon Capital Investments Limited · JSE:TMT | US$15.45M | US$23.57M | n/a | 1.4× | 36.8× | 1.0× | −23.3% | 0.8× | n/a |
| Median of the others | US$17.35M | US$17.46M | 3.3× | 5.9× | 3.1× | 0.7× | 87.8% | 0.1× | 1.08 |
Forecasts
Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 128.00 GBX · Analysts' mean
- EPS, year to Dec 2026
- 0.68 · 1 analyst
- Revenue, year to Dec 2026
- 3.16M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Ilian Iliev | Chief Executive Officer |
| Anesh Patel | Group Chief Financial Officer |
| Edward Hooper | Executive Director |
| Tom Rudd | Business Development Manager (EIS Fund) |
Board
| Director | Role |
|---|---|
| Charles Spicer | Chairman of the Board |
| Edward Hooper | Executive Director |
| Ilian Iliev | Chief Executive Officer |
| Jonathan Robinson | Non-Executive Director |
Events
Calls
All 14 calls
| Call | When | Status |
|---|---|---|
| EMV Capital (LSE:EMVC) — Preliminary Results | Mon, Jun 05, 2023 · 6:00 AM ET | Replay |
| EMV Capital (LSE:EMVC) — Results and Company Update | Thu, May 12, 2022 · 11:00 AM ET | Replay |
| EMV Capital (LSE:EMVC) — Results and Company Update | Thu, Oct 07, 2021 · 11:00 AM ET | Replay |
| EMV Capital (LSE:EMVC) — Results and Company Update | Wed, Apr 21, 2021 · 11:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2026 | Apr 1, 2026 | 0.0% |
| Q2 2025 | Sep 30, 2025 | +16.5% |
| Q2 2024 | Aug 13, 2024 | 0.0% |
| Q2 2022 | Sep 30, 2022 | +16.5% |
| Q2 2021 | Sep 29, 2021 | +2.4% |
| Q4 2020 | Mar 31, 2021 | +6.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 27 slides | Sep 24, 2026 |
| FY2025 Earnings Presentation | Earnings | 26 slides | May 19, 2026 |
| Investor Presentation (February 2026) | Investor deck | 29 slides | Feb 26, 2026 |
| Investor Presentation (December 2025) | Investor deck | 27 slides | Dec 1, 2025 |
| H1 2025 Earnings Presentation | Earnings | 31 slides | Sep 30, 2025 |
| FY2024 Earnings Presentation | Earnings | 35 slides | June 2025 |
| H1 2024 Earnings Presentation | Earnings | 23 slides | Oct 1, 2024 |
| NetScientific — Corporate Update (March 2024) | Corporate update | 15 slides | Mar 19, 2024 |
| NetScientific — H1 2023 Earnings Presentation | Earnings | 23 slides | Oct 3, 2023 |
| NetScientific — Mello2023 Investor Conference (May 2023) | Conference | 14 slides | May 23, 2023 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| NetScientific — Proactive One2One Investor Forum (January 2023) | Conference | 10 slides | Jan 26, 2023 |
| NetScientific — H1 2021 Earnings Presentation | Earnings | 20 slides | September 2021 |
| Investor Presentation (2021) | Investor deck | 12 slides | Aug 28, 2021 |
| NetScientific — Investor Meet Company (April 2021) | Conference | 20 slides | Apr 21, 2021 |
| ProAxsis — 2nd Annual Capital Markets Day (March 2017) | Conference | 23 slides | March 2017 |
| Vortex BioSciences — Investor Day (June 2016) | Investor day | 32 slides | Jun 14, 2016 |
| Glycotest — Investor Day (May 2015) | Investor day | 13 slides | May 15, 2015 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of new ordinary shares Closed: £880,000 raised · £0.5 a share · EMV Capital Partners Limited Dealers: EMV Capital Partners Limited (lead) Buyers: A Beckman plc SSAS (100,000 New Shares); Ilian Iliev (200,000 New Shares; 14.11% of enlarged share capital on Admission assuming Retail Offer fully subscribed) Insiders: CEO Ilian Iliev subscribed for 200,000 New Shares, paid by releasing the Company from £100,000 of his 2023 annual bonus Use of proceeds: To develop the Company's growth strategy | Dec 5, 2024 | US$1.12M |
| New ordinary shares Closed: £567,248 raised · £0.5 a share · Winterflood Securities Ltd Dealers: Winterflood Securities Ltd Buyers: Charles Spicer (40,000 New Shares); Ed Hooper (180,000 New Shares) Insiders: Non-Executive Chair Charles Spicer and Executive Director Ed Hooper subscribed for 40,000 and 180,000 New Shares respectively via their SIPPs Use of proceeds: To develop the Company's growth strategy | Dec 5, 2024 | US$723,223 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in GBP
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.87M | 2.45M | 1.45M | 1.00M | 1.11M | 394.0K | 735.0K | 245.0K | 171.0K | 518.0K |
| Cost of revenue | 616.0K | 360.0K | 219.0K | 222.0K | 118.0K | 46.0K | 117.0K | 78.0K | 80.0K | 255.0K |
| Gross profit | 2.25M | 2.09M | 1.23M | 782.0K | 989.0K | 348.0K | 618.0K | 167.0K | 91.0K | 263.0K |
| Research and development | 1.22M | 1.17M | 1.48M | 1.37M | 1.32M | 1.23M | 1.98M | 524.0K | 997.0K | 7.44M |
| Selling, general and administrative | 3.10M | 4.01M | 3.96M | 3.72M | 2.57M | 1.99M | 2.08M | 2.82M | 3.29M | 5.00M |
| Operating income | -1.88M | -3.39M | -2.64M | -3.74M | -2.96M | -2.46M | -3.63M | -4.11M | -4.43M | -12.4M |
| Depreciation and amortization | 358.0K | 411.0K | 462.0K | 347.0K | 248.0K | 153.0K | 74.0K | 262.0K | 221.0K | 141.0K |
| EBITDA | -1.52M | -2.98M | -2.18M | -3.39M | -2.71M | -2.31M | -3.56M | -3.84M | -4.21M | -12.3M |
| Interest expense | 165.0K | 200.0K | 171.0K | 55.0K | 22.0K | 28.0K | 22.0K | 12.0K | 11.0K | 8.00K |
| Income before tax | -690.0K | -3.73M | -2.90M | -3.71M | -2.92M | -2.38M | -3.63M | -4.07M | -4.40M | -12.4M |
| Income tax | -49.0K | -15.0K | -29.0K | -37.0K | -61.0K | -43.0K | -88.0K | -73.0K | -202.0K | 18.0K |
| Net income | -21.0K | -3.06M | -2.64M | -3.09M | -2.38M | -1.61M | -4.49M | -8.33M | -8.32M | -11.2M |
| Earnings per share, basic | -0.00 | -0.13 | -0.11 | -0.14 | -0.13 | -0.29 | -0.57 | -1.10 | -1.36 | -2.19 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 511.0K | 949.0K | 347.0K | 580.0K | 2.35M | 1.03M | 1.22M | 2.85M | 6.87M | 9.46M |
| Receivables | 893.0K | 825.0K | 726.0K | 475.0K | 1.43M | 279.0K | 424.0K | 185.0K | 365.0K | 1.04M |
| Inventory | 98.0K | 81.0K | 52.0K | 76.0K | 67.0K | 74.0K | 30.0K | 37.0K | 86.0K | |
| Current assets | 1.62M | 2.07M | 1.35M | 1.59M | 4.38M | 2.08M | 4.09M | 3.96M | 7.97M | 11.0M |
| Goodwill | 669.0K | 669.0K | 669.0K | 669.0K | 669.0K | 669.0K | ||||
| Total assets | 19.8M | 19.5M | 22.5M | 29.0M | 20.7M | 8.07M | 6.17M | 7.20M | 11.8M | 15.1M |
| Accounts payable | 1.35M | 1.31M | 840.0K | 497.0K | 219.0K | 173.0K | 291.0K | 148.0K | 233.0K | 617.0K |
| Current liabilities | 5.76M | 4.48M | 3.58M | 2.72M | 1.62M | 720.0K | 816.0K | 966.0K | 905.0K | 2.17M |
| Long-term debt | 22.0K | 898.0K | 1.64M | 719.0K | 432.0K | |||||
| Total debt | 2.60M | 1.53M | 2.53M | 1.25M | 654.0K | 509.0K | 437.0K | 200.0K | 198.0K | 208.0K |
| Total liabilities | 6.13M | 5.43M | 5.35M | 3.71M | 2.18M | 1.17M | 1.06M | 1.03M | 975.0K | 2.25M |
| Shareholders' equity | 15.2M | 15.1M | 17.8M | 25.8M | 18.5M | 6.74M | 5.47M | 12.1M | 15.4M | 16.7M |
| Shares outstanding | 27.8M | 24.3M | 23.5M | 22.3M | 18.1M | 5.61M | 7.86M | 7.58M | 6.10M | 5.11M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.24M | -1.78M | -3.14M | -2.56M | -3.48M | -2.79M | -4.12M | -8.28M | -10.6M | -12.8M |
| Capital spending | -32.0K | -185.0K | -366.0K | -601.0K | -62.0K | -89.0K | -6.00K | -112.0K | -399.0K | -470.0K |
| Free cash flow | -1.27M | -1.97M | -3.51M | -3.16M | -3.54M | -2.88M | -4.13M | -8.39M | -11.0M | -13.3M |
| Cash from investing | 279.0K | 12.0K | 1.11M | -1.08M | -3.46M | -959.0K | 35.0K | -88.0K | 934.0K | -1.67M |
| Cash from financing | 477.0K | 2.57M | 1.39M | 1.74M | 8.02M | 1.89M | 4.31M | 4.67M | 7.49M | 70.0K |
| Change in cash | -491.0K | 802.0K | -652.0K | -1.86M | 1.08M | -1.82M | 137.0K | -3.96M | -2.59M | -13.8M |
Cap table
Built by 6ix from EMV Capital PLC’s releases · as of Dec 5, 2024
- Common shares
- 28,205,938
- Fully diluted
- 28,205,938
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 28,205,938 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 28,205,938 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anesh Patel | Group Chief Financial Officer · Since at least May 19, 2026 |
| Charles Spicer | Chairman of the Board · Since at least May 19, 2026 |
| Edward Hooper | Executive Director · Since at least Jun 30, 2025 |
| Ilian Iliev | Chief Executive Officer · Since at least Oct 13, 2026 |
| Jonathan Robinson | Non-Executive Director · Since at least May 19, 2026 |
| Stephen Crowe | Until Nov 24, 2025 · Past |
| Tom Rudd | Business Development Manager (EIS Fund) · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about EMV Capital PLC.